These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24951228)

  • 21. Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.
    Park YS; Lee CH; Kim BH; Lee J; Choi JW; Kim KA; Ahn JH; Park CM
    Magn Reson Imaging; 2013 Sep; 31(7):1137-42. PubMed ID: 23688409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C.
    Miyagawa S; Kawasaki S; Makuuchi M
    Hepatology; 1996 Aug; 24(2):307-10. PubMed ID: 8690397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular Carcinoma: Does the Background Liver With or Without Cirrhosis Matter?
    Jain A; Mazer B; Deng Y; Ciarleglio M; Jain D; Taddei T; Zhang X
    Am J Clin Pathol; 2022 Feb; 157(2):305-313. PubMed ID: 34542582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma: development and early detection.
    Robinson P
    Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S128-31. PubMed ID: 18852086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidisciplinary approach for HCC patients: hepatology for the oncologists.
    Barone C; Koeberle D; Metselaar H; Parisi G; Sansonno D; Spinzi G
    Ann Oncol; 2013 Apr; 24 Suppl 2():ii15-23. PubMed ID: 23715939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients.
    Nzeako UC; Goodman ZD; Ishak KG
    Am J Clin Pathol; 1996 Jan; 105(1):65-75. PubMed ID: 8561091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
    Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver.
    Laurent C; Blanc JF; Nobili S; Sa Cunha A; le Bail B; Bioulac-Sage P; Balabaud C; Capdepont M; Saric J
    J Am Coll Surg; 2005 Nov; 201(5):656-62. PubMed ID: 16256906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential diagnosis of hepatocellular nodular lesions.
    Hytiroglou P; Theise ND
    Semin Diagn Pathol; 1998 Nov; 15(4):285-99. PubMed ID: 9845429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiologic factors and clinical presentation of hepatocellular carcinoma: differences between cirrhotic and noncirrhotic Italian patients.
    Nzeako UC
    Cancer; 1995 Sep; 76(5):915. PubMed ID: 8625198
    [No Abstract]   [Full Text] [Related]  

  • 33. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis.
    Hanna RF; Kased N; Kwan SW; Gamst AC; Santosa AC; Hassanein T; Sirlin CB
    AJR Am J Roentgenol; 2008 Jan; 190(1):47-57. PubMed ID: 18094293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective audit to determine the diagnostic accuracy of Primovist-enhanced MRI in the detection of hepatocellular carcinoma in cirrhosis with explant histopathology correlation.
    Baird AJ; Amos GJ; Saad NF; Benson MD
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):314-20. PubMed ID: 23721140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kentucky hepatoma: epidemiologic variant or same problem in a different region?
    Martin RC; Loehle J; Scoggins CR; McMasters KM
    Arch Surg; 2007 May; 142(5):431-6; discussion 436-7. PubMed ID: 17515484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.
    Bhartia B; Ward J; Guthrie JA; Robinson PJ
    AJR Am J Roentgenol; 2003 Mar; 180(3):577-84. PubMed ID: 12591657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma.
    Ishizawa T; Masuda K; Urano Y; Kawaguchi Y; Satou S; Kaneko J; Hasegawa K; Shibahara J; Fukayama M; Tsuji S; Midorikawa Y; Aburatani H; Kokudo N
    Ann Surg Oncol; 2014 Feb; 21(2):440-8. PubMed ID: 24254203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver.
    Wörns MA; Bosslet T; Victor A; Koch S; Hoppe-Lotichius M; Heise M; Hansen T; Pitton MB; Niederle IM; Schuchmann M; Weinmann A; Düber C; Galle PR; Otto G
    Scand J Gastroenterol; 2012 Jun; 47(6):718-28. PubMed ID: 22472070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
    Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
    Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.